These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 35292576

  • 1. Lessons Learned from the Japanese Encephalitis Vaccine Introduction in India That Supported the Introduction of Ivermectin-Diethylcarbamazine-Albendazole for Lymphatic Filariasis Elimination.
    Ghosh RS, Haldar P, Jacobson J.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):48-55. PubMed ID: 35292576
    [Abstract] [Full Text] [Related]

  • 2. Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned.
    Tripathi B, Roy N, Dhingra N.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):29-38. PubMed ID: 35292580
    [Abstract] [Full Text] [Related]

  • 3. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M, Lepaitai HB, Bhagirov R, Padmasiri E, Naseri T, Thomsen R, Won KY, Brant TA, Dodd E, Nua MT, Utu F, Tufa A, Chutaro E, Camacho J, Suiaunoa-Scanlan L, Thean LJ, Mani J, Hardy M, Samuela J, Romani L, Kaldor J, Steer AC, Faktaufon D, Bechu V, Naqio F, Sosene V, Sekihara M, Otaki J, Buhagiar TS, Yajima A.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):39-47. PubMed ID: 35292579
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Accelerating the Uptake of WHO Recommendations for Mass Drug Administration Using Ivermectin, Diethylcarbamazine, and Albendazole.
    King JD, Jacobson J, Krentel A.
    Am J Trop Med Hyg; 2022 May 11; 106(5_Suppl):26-28. PubMed ID: 35292578
    [Abstract] [Full Text] [Related]

  • 6. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU, King CL, Jacobson JA, Weil GJ.
    PLoS Negl Trop Dis; 2017 Jan 11; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract] [Full Text] [Related]

  • 7. An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
    Supali T, Djuardi Y, Christian M, Iskandar E, Alfian R, Maylasari R, Destani Y, Lomiga A, Minggu D, Lew D, Bogus J, Weil GJ, Fischer PU.
    PLoS Negl Trop Dis; 2021 Mar 11; 15(3):e0009294. PubMed ID: 33780481
    [Abstract] [Full Text] [Related]

  • 8. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV.
    Parasitology; 2000 Mar 11; 121 Suppl():S147-60. PubMed ID: 11386686
    [Abstract] [Full Text] [Related]

  • 9. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH.
    Lancet; 2006 Mar 25; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P, Subramanian S, de Vlas SJ, Vinubala C, Stolk WA.
    Parasit Vectors; 2016 Sep 13; 9(1):501. PubMed ID: 27624157
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA, Gogtay NJ, Garg BS, Deshmukh PR, Rajgor DD, Kadam VS, Thakur PA, Gupta A, Ingole NS, Lazdins-Helds JK.
    Parasitol Res; 2017 Oct 13; 116(10):2683-2694. PubMed ID: 28785847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.